Coleen Rooney reveals remark Trump made about her at White House meetingSpanish Results
Srinagar, Nov 24: To take first-hand appraisal of ongoing Water Supply Schemes (WSS) & Filtration plants under execution, the Deputy Commissioner (DC) Srinagar, Dr Bilal Mohi-Ud-Din Bhat today made an extensive tour of various water supply schemes supplying potable drinking water to Srinagar City. The Deputy Commissioner accompanied by Chief Planning Officer, Fayaz Ahmad, Executive Engineer PHE Master Plan Division, Peerzada Shayeq Ahmad, Executive Engineer PHE City Water Works Division Anbreen Anjum and other officers also inspected the upgradation works taken up to further strengthen and ensure uninterrupted supply of drinking water to citizens. At Nishat, while inspecting functioning of 19 MGD Flirtation Plant, the DC was apprised that plant caters to a population of around 5 lakh of Srinagar District. He was informed that Activated Carbon Chamber is being constructed under Amrut-2.0 programme with activated carbon based on coconut shell charcoal which will address the colour and odour issues of raw water. On the occasion, the DC evaluated the progress of the project and emphasised for maintaining quality and timely completion of works to ensure improved drinking water facilities to the people in the specified quality and quantity, envisaged under the scheme. The DC also recommended the use of latest technologies available in the sector of Water treatment. The DC was informed that the total demand of Srinagar City with regard to water supply is 85 MGD and under AMRUT-2.0 programme 100% saturation of households shall be achieved. During the visit, the DC also took stock of water supply catering to Srinagar areas from 30 MGD capacity Rangil Water Supply schemes. On the occasion, the DC was informed that the plant has a total capacity of supplying 30 Million Gallons per day and serve a population of around 10 lakh souls. The DC also inspected 6.8 MGD capacity water treatment plant at Alusteng. He inspected various units of these Rapid Sand Filtration plants and took a thorough review of all the tests being conducted on daily basis in the well established plant labs, for ensuring clean and safe Drinking water fit for human consumption.
None
(Azacitidine + cedazuridine) is under clinical development by Taiho Oncology and currently in Phase III for Chronic Myelomonocytic Leukemia (CMML). According to GlobalData, Phase III drugs for Chronic Myelomonocytic Leukemia (CMML) have a 57% phase transition success rate (PTSR) indication benchmark for progressing into Pre-Registration. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. (Azacitidine + cedazuridine) overview ASTX-030, a fixed dose combination of azacitidine and cedazuridine is under development for the treatment of myelodysplastic syndromes (MDS), chronic myelocytic leukemia (CML), refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). It is administered by oral route. It acts by targeting DNA (cytosine 5) methyltransferase 1 and cytosine deaminase (CDA). The drug candidate is being developed based on Pyramid technology. Taiho Oncology overview Taiho Oncology, a subsidiary of Taiho Pharmaceutical Co Ltd, is a provider of cancer treatments and solutions. The company manufactures and markets cancer anti-metabolites as well as targeted small molecule inhibitors. Its products portfolio includes oral drugs for the treatment of gastric cancer, colorectal cancer and a variety of solid tumours. Taiho Oncology’s pipeline products includes anti metabolic agents and selectively targeted agents. The company’s LONSURF is an anti-cancer drug for the treatment of metastatic colorectal cancer. Taiho Oncology is headquartered in Princeton, New Jersey, the US. For a complete picture of (Azacitidine + cedazuridine)’s drug-specific PTSR and LoA scores, This content was updated on 12 April 2024 From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s .
Thomas scores 25 as Austin Peay defeats Georgia State 62-50TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
Lesabelimab by Dragonboat Biopharmaceutical (Shanghai) for Endometrial Cancer: Likelihood of ApprovalNHL DoPS Delivers Official Ruling on Zach Whitecloud's Potential Suspension for Hit on Matthew Knies
Guess (NYSE:GES) Misses Q3 Revenue Estimates, Stock DropsYou don't need us to tell you that is a bonafide capital-M Movie Star (his roles in , , and can do that for us), but what we tell you is that his upcoming role in the Bob Dylan biopic has earned a stamp of approval from the music legend himself. Dylan took to social media to write a message about the flick, particularly giving Timmy high praise. "There’s a movie about me opening soon called (what a title!). Timothée Chalamet is starring in the lead role. Timmy’s a brilliant actor so I’m sure he’s going to be completely believable as me. Or a younger me. Or some other me," the "Knockin' on Heaven's Door" singer . He added, "The film’s taken from Elijah Wald’s – a book that came out in 2015. It’s a fantastic retelling of events from the early ‘60s that led up to the fiasco at Newport. After you’ve seen the movie read the book." Floored. I am so grateful. Thank you Bob — Timothée Chalamet (@RealChalamet) Amid a trip to Dylan's homeland of Minnesota for a screening and Q&A of the film, Timmy reacted to the compliment. "Floored. I am so grateful. Thank you Bob," the Oscar-nominated star wrote. Of course, Timmy's ~premiere~ fan page ClubChalamet (who happen to be huge fans of, FYI) also weighed in on the sweet moment. The admin responded to Dylan's original post with a snap of Elijah Wald’s , writing, "Thanks Bob! We're all really excited to watch Timothée in ! And I recently started to read Wald's book!" Thanks Bob! We're all really excited to watch Timothée in A Complete Unknown! And I recently started to read Wald's book! 👍🏼 — Club Chalamet 💫 (@ClubChalamet) Ditto, ClubChalamet. Ditto. 🥹
Teradyne: How To Get Better Protection With Still Some Unlimited Upside
Cal staves off Sacramento State for third straight winBest Cyber Monday Tech Deals: Essentials to Get for the Holidays, Including Nintendo Switch, Sony, Xbox & More
Chuck Woolery, smooth-talking game show host of ‘Love Connection’ and ‘Scrabble,’ dies at 83